Cambridge–AstraZeneca

2 funding calls

Upcoming first, then newest

AZ funded Non-clinical PhD Studentship (Fixed Term) in selective nanoparticle targeting of senescent alveolar epithelium using an alveolar organoid model

University of Cambridge

…to lung epithelial cells in a Cambridge–AstraZeneca doctoral project. Research uses human alveolar organoids, engineered carriers and automated screening to evaluate drug selection, delivery and functional responses relevant to pulmonary fibrosis. The four-year studentship begins in October 2027.

Closes Dec 8

Nanomedicine

AstraZeneca Non-Clinical PhD Studentship in Development of an Integrated Pre-Clinical Pipeline for Safety Assessment of Small Molecule and Peptide-Based Radioconjugates

University of Cambridge

…The Cambridge–AstraZeneca project combines in-vivo PET imaging with multimodal tissue analysis to study distribution and toxicity of targeted radionuclide therapies. Four years of doctoral funding support work across academic and industrial research environments.

Closed Oct 30

Toxicology

Cambridge–AstraZeneca

Filters

When

Field

2 funding calls

AZ funded Non-clinical PhD Studentship (Fixed Term) in selective nanoparticle targeting of senescent alveolar epithelium using an alveolar organoid model

AstraZeneca Non-Clinical PhD Studentship in Development of an Integrated Pre-Clinical Pipeline for Safety Assessment of Small Molecule and Peptide-Based Radioconjugates